A research study investigating the effect of NNC0497-0040 in healthy participants, participants with overweight or obesity, and participants with type 1 diabetes with overweight or obesity.
Phase 1 – testing safety in a small group of people
Conditions:
Type I diabetes
Sponsor: Novo Nordisk A/S
trial.available_in:
БГ
Overview
Trial status: Authorised
Who can participate
Age group: 18-64 years
Gender: Female, Male
Target enrollment: 146 participants
БГ